Getting new auth cookie, if you see this message a lot, tell someone!

Index by author

February 01, 2023; Volume 90,Issue 2

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Mandell, Brian F.
1. You have access
  Myasthenia gravis: An update for internists
  Brian F. Mandell, MD, PhD
  Cleveland Clinic Journal of Medicine February 2023, 90 (2) 72-73; DOI: https://doi.org/10.3949/ccjm.90b.02023
  Recognizing the spectrum of the disease in patients’ complaints enhances our clinical reasoning skills when faced with the extremely commonly expressed symptom of “fatigue.”
2. You have access
  Our Peer-Reviewers For 2022
  Brian F. Mandell, MD, PhD
  Cleveland Clinic Journal of Medicine February 2023, 90 (2) 78;
Morren, John A.
1. You have access
  What are the treatment options for myasthenia gravis if first-line agents fail?
  Christopher Zust, MD and John A. Morren, MD
  Cleveland Clinic Journal of Medicine February 2023, 90 (2) 81-84; DOI: https://doi.org/10.3949/ccjm.90a.22022
  From 5% to 20% of patients may have a suboptimal response or prohibitive adverse effects over a period of a few weeks to 3 months.
2. You have access
  Myasthenia gravis: Frequently asked questions
  John A. Morren, MD and Yuebing Li, MD, PhD
  Cleveland Clinic Journal of Medicine February 2023, 90 (2) 103-113; DOI: https://doi.org/10.3949/ccjm.90a.22017
  Who is at risk? Which tests should be ordered? How does the disease course affect management decisions? What instructions should you give patients? And other questions.